| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.092 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |